Brief: Adocia Says Sanofi’S Exclusive Right For Partnership Agreement For Development Of M1Pram Has Expired
03/07/2026 17:17
BRIEF-Adocia Says Sanofi’S Exclusive Right For Partnership Agreement For Development Of M1Pram Has Expired July 3 (Reuters) - Adocia SA ADOC.PA:
ANNOUNCES EXPIRY OF SANOFI’S EXCLUSIVE RIGHT TO NEGOTIATE A PARTNERSHIP AGREEMENT FOR THE DEVELOPMENT OF M1PRAM
Source text: [ID:]
Further company coverage: ADOC.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Adocia SA
See all newsFrench biopharma firm Adocia H1 revenue drops on weaker feasibility study income
Brief: Adocia H1 Operating Income EUR -7.947 Million
Brief: Adocia Says Sanofi’S Exclusive Right For Partnership Agreement For Development Of M1Pram Has Expired
Brief: Adocia And Vester Finance Sign Shareholder Loan Agreement
Brief: Adocia Sees Challenges With GLP-1, Amylin & Other Metabolic Peptides